The case for stopping cervical screening at age 50

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 104, Issue 5, 1997, Pages 586-589

  Cruickshank, Margaret E ^a   Angus, Valerie ^a   Kelly, Margaret ^a   McPhee, Susan ^a   Kitchener, Henry C ^a  

^a NHS GRAMPIAN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER SCREENING; CLINICAL PROTOCOL; COST BENEFIT ANALYSIS; FEMALE; HEALTH PROGRAM; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; RESOURCE ALLOCATION; UNITED KINGDOM; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY;

AGE FACTORS; AGED; BIOPSY; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; MASS SCREENING; PREVALENCE; REFUSAL TO TREAT; RETROSPECTIVE STUDIES; SCOTLAND; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0030964968     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1997.tb11537.x     Document Type: Article

References (3)

1. Paraskevaidis E, Kitchener HC, Miller ID, Mann EMF, Jandial L, Fisher PM. A population based clinico-pathologic study of micro-invasive disease of the cervix. Gynaecol Oncol 1992; 45: 9–12.
2. van Wijngaarden WJ, Duncan ID. Rationale for stopping cervical screening in women over 50. BMJ 1993; 306:967–971.
3. Cancer Research Campaign. Cancer of the cervix uteri. Fact Sheet 12.2, 1994.